Bitter melon peptide effectively regulates diabetes mellitus patients' blood sugar levels. - GreenMedInfo Summary
mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients' Blood Sugar Levels.
Nutrients. 2020 Apr 28 ;12(5). Epub 2020 Apr 28. PMID: 32354072
This study was conducted to test the effectiveness of a particular bitter melon peptide (BMP), with a specific sequence of 19 amino acids (mcIRBP-19), in regulating diabetic patients' blood glucose. In order to test the product with the specially processed BMP, a total of 142 diabetic patients were solicited as study subjects, of which 64 were assigned to an experiment group and 78 to a control group. Biochemical data were compared with a pairedtest to verify the significance of changes over different time periods. The clinical results showed that BMP started to improve the subjects' glycated hemoglobin (HbA1c) levels at the end of the second month (T2), with mean values being significantly lowered from 7.8± 1.4% (T0) to 7.5 ± 1.4% (T2) (= 0.004). The values reduced continuously, eventually reaching 7.4± 1.1% (= 0.000) at the end of the experiment (T3). HbA1c levels for the control group were 7.5± 1.2% in T0 and 7.5 ± 1.1% (T3), and not significantly different (= 0.852) over the same period. This study provides clinical evidence that helps to verify the effectiveness of the new BMP product in regulating diabetic patients' blood sugar levels.